@article{sodhi_risk_2023,
	title = {Risk of {Gastrointestinal} {Adverse} {Events} {Associated} {With} {Glucagon}-{Like} {Peptide}-1 {Receptor} {Agonists} for {Weight} {Loss}},
	volume = {330},
	issn = {1538-3598},
	doi = {10.1001/jama.2023.19574},
	language = {eng},
	number = {18},
	journal = {JAMA},
	author = {Sodhi, Mohit and Rezaeianzadeh, Ramin and Kezouh, Abbas and Etminan, Mahyar},
	month = nov,
	year = {2023},
	keywords = {Anti-Obesity Agents, Diabetes Mellitus, Type 2, Gastrointestinal Diseases, Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptides, Humans, Hypoglycemic Agents, Liraglutide, Overweight, Weight Loss},
	pages = {1795--1797},
}

{"_id":"4oJzM8MWRcaC9vhq7","bibbaseid":"sodhi-rezaeianzadeh-kezouh-etminan-riskofgastrointestinaladverseeventsassociatedwithglucagonlikepeptide1receptoragonistsforweightloss-2023","author_short":["Sodhi, M.","Rezaeianzadeh, R.","Kezouh, A.","Etminan, M."],"bibdata":{"bibtype":"article","type":"article","title":"Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss","volume":"330","issn":"1538-3598","doi":"10.1001/jama.2023.19574","language":"eng","number":"18","journal":"JAMA","author":[{"propositions":[],"lastnames":["Sodhi"],"firstnames":["Mohit"],"suffixes":[]},{"propositions":[],"lastnames":["Rezaeianzadeh"],"firstnames":["Ramin"],"suffixes":[]},{"propositions":[],"lastnames":["Kezouh"],"firstnames":["Abbas"],"suffixes":[]},{"propositions":[],"lastnames":["Etminan"],"firstnames":["Mahyar"],"suffixes":[]}],"month":"November","year":"2023","keywords":"Anti-Obesity Agents, Diabetes Mellitus, Type 2, Gastrointestinal Diseases, Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptides, Humans, Hypoglycemic Agents, Liraglutide, Overweight, Weight Loss","pages":"1795–1797","bibtex":"@article{sodhi_risk_2023,\n\ttitle = {Risk of {Gastrointestinal} {Adverse} {Events} {Associated} {With} {Glucagon}-{Like} {Peptide}-1 {Receptor} {Agonists} for {Weight} {Loss}},\n\tvolume = {330},\n\tissn = {1538-3598},\n\tdoi = {10.1001/jama.2023.19574},\n\tlanguage = {eng},\n\tnumber = {18},\n\tjournal = {JAMA},\n\tauthor = {Sodhi, Mohit and Rezaeianzadeh, Ramin and Kezouh, Abbas and Etminan, Mahyar},\n\tmonth = nov,\n\tyear = {2023},\n\tkeywords = {Anti-Obesity Agents, Diabetes Mellitus, Type 2, Gastrointestinal Diseases, Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptides, Humans, Hypoglycemic Agents, Liraglutide, Overweight, Weight Loss},\n\tpages = {1795--1797},\n}\n\n\n\n\n\n\n\n","author_short":["Sodhi, M.","Rezaeianzadeh, R.","Kezouh, A.","Etminan, M."],"key":"sodhi_risk_2023","id":"sodhi_risk_2023","bibbaseid":"sodhi-rezaeianzadeh-kezouh-etminan-riskofgastrointestinaladverseeventsassociatedwithglucagonlikepeptide1receptoragonistsforweightloss-2023","role":"author","urls":{},"keyword":["Anti-Obesity Agents","Diabetes Mellitus","Type 2","Gastrointestinal Diseases","Glucagon-Like Peptide-1 Receptor Agonists","Glucagon-Like Peptides","Humans","Hypoglycemic Agents","Liraglutide","Overweight","Weight Loss"],"metadata":{"authorlinks":{}},"downloads":0,"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/ArthurLee1999","dataSources":["PS7iNi9NSaRnsipEv"],"keywords":["anti-obesity agents","diabetes mellitus","type 2","gastrointestinal diseases","glucagon-like peptide-1 receptor agonists","glucagon-like peptides","humans","hypoglycemic agents","liraglutide","overweight","weight loss"],"search_terms":["risk","gastrointestinal","adverse","events","associated","glucagon","peptide","receptor","agonists","weight","loss","sodhi","rezaeianzadeh","kezouh","etminan"],"title":"Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss","year":2023}